Company name: Beleave Kannabis (CNQ: BE)
Description: Producer of medical and recreational cannabis with the goal of bridging the gap between science and tradition to develop pharma-grade extracts and derivatives. The Canadian based company runs a vertically integrated operation to cultivate high-quality cannabis flower, oil, and extracts which are available online and in storefronts.
Year founded: 2010
Industry: Consumer Products and Services (B2C) | Group: Consumer Non-Durables | Code:
Start up capital raised (USD Million): 44.54
Business status: Profitable
Ownership: Publicly Held
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company (CNQ:BE) is in talks to receive CAD 30 million of development capital from Alumina Partners through a private placement as of September 14, 2018. This agreement underpins Beleave’s ability to execute on growth initiatives in line with Alumina Partners’s strategic plan without any firm obligation to use this capital.
Number of active investors:
Profile last updated: 28-Nov-2018
Last known valuation: 60.00
Last known valuation date: 18-Sep-2017